Salim Essakali

Salim Essakali is an accomplished professional with over 20 years of experience in the biopharmaceutical and medical device industries. Currently serving as Vice President and Head of OEM & Enzyme Business at QIAGEN since May 2022, Salim has previously held key leadership positions at Solis BioDyne, Boston Scientific, and QIAGEN, contributing to global sales, marketing, and product management. Salim's educational background includes an MBA with a focus on M&As and Post Merger Integrations from The Julius Maximilians University of Würzburg and a Master of Science in biomarker discovery in translational medicine from the University of Düsseldorf.